Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for autoimmune disease.
Link as first comment.
#longevity #geroscience #InsilicoMedicine #ISM9546 #autoimmunedisease
Link as first comment.
#longevity #geroscience #InsilicoMedicine #ISM9546 #autoimmunedisease
October 22, 2026 at 11:25 AM
Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for autoimmune disease.
Link as first comment.
#longevity #geroscience #InsilicoMedicine #ISM9546 #autoimmunedisease
Link as first comment.
#longevity #geroscience #InsilicoMedicine #ISM9546 #autoimmunedisease
Insilico Medicine Breaks New Ground with AI Innovation for Autoimmune Treatments#United_States#Cambridge#Autoimmune_Disease#Insilico_Medicine#VAV1_degrader
Insilico Medicine Breaks New Ground with AI Innovation for Autoimmune Treatments
Insilico Medicine announces ISM9546, a groundbreaking AI-designed VAV1 degrader aimed at autoimmune diseases, marking a record-setting milestone in drug development.
third-news.com
October 13, 2026 at 1:45 PM
Insilico Medicine Breaks New Ground with AI Innovation for Autoimmune Treatments#United_States#Cambridge#Autoimmune_Disease#Insilico_Medicine#VAV1_degrader